MedTrace Logo

Post-market Evaluation of OdySight App to Monitor Near Visual Acuity at Home (TIL002)

NCT05510479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2022-08-22

No results posted yet for this study

Summary

OdySight is a mobile application allowing self-testing of visual parameters including near visual acuity and communication of the data to an online dashboard to patient's doctors. TIL-002 post-market clinical trial objective is to evaluate the near visual acuity at home, measured with OdySight application in comparison to the standardized methods. The clinical trial is intended to prove that OdySight can provide relevant data and participate in the remote monitoring of subject vision.

Conditions

  • Visual Impairment

Interventions

OTHER

Software as medical device

At home measurements of visual acuity through a mobile app

Sponsors & Collaborators

  • Tilak Healthcare

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2022-05-11
Completion
2022-05-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05510479 on ClinicalTrials.gov